Blood pressure is a critical determinant of cardiovascular morbidity and mortality. It is affected by environmental factors, but has a strong heritable component. Despite recent large genome-wide association studies, few genetic risk factors for blood pressure have been identified. Epidemiological studies suggest associations between blood pressure and several diseases and traits, which may partly arise from a shared genetic basis (genetic pleiotropy). Using genome-wide association studies summary statistics and a genetic pleiotropy-informed conditional False Discovery Rate method, we systematically investigated genetic overlap between systolic blood pressure and 12 co-morbid traits and diseases. We found significant 'enrichment' of single nucleotide polymorphisms associated with systolic blood pressure as a function of their association with body mass index, low density lipoprotein, waist hip ratio, schizophrenia, bone mineral density, type 1 diabetes and celiac disease. In contrast, the magnitude of enrichment due to shared polygenic effects was smaller with the other phenotypes (triglycerides, high density lipoproteins, type 2 diabetes, rheumatoid arthritis, and height). Applying the conditional False Discovery Rate method to the enriched phenotypes, we identified 62 loci associated with systolic blood pressure (False Discovery Rate < 0.01), including 42 novel loci. The observed polygenic overlap between systolic blood pressure and several related disorders indicates that the epidemiological associations are not mediated solely via lifestyle factors, but also reflect an etiological relation that warrants further investigation. The new gene loci identified implicate novel genetic mechanisms related to lipid biology and the immune system in systolic blood pressure.
INTRODUCTION
High blood pressure affects over one billion individuals 1 , and even small increments increase morbidity and mortality. Though heritability estimates of systolic blood pressure (SBP) exceed 50% 2, 3 , genes identified to date explain only a small proportion of heritability 4 . It has been argued that the genetic architecture of blood pressure regulation in the general population cannot be explained by commonly occurring genetic variation, suggesting that genome-wide association studies (GWAS) will continue to fail in hypertension 5, 6 . However, recent results indicate that GWAS have the potential to explain a greater proportion of the heritability of most common complex phenotypes 7, 8 . This polygenic architecture suggests that a large number of Single Nucleotide Polymorphisms (SNPs) will have associations too weak to be identified using traditionally employed analytic methods and limited sample sizes 9 . This has led to recent National Institute of Health and European Union calls for new cost-effective analytical methods to reliably identify a larger proportion of SNPs associated with complex diseases and traits using existing GWAS since recruitment and genotyping of new participants are expensive. One such approach relies on genetic pleiotropy 10 , i.e. the association of individual SNPs or genes with two or more phenotypes. Given the large number of traits in humans, and the relatively small number of genes, some genes are likely to affect multiple traits. Moreover, since there are often overlapping traits among behaviorally or clinically defined phenotypes, shared genetic influences between such phenotypes are likely.
Epidemiological studies have identified several major risk factors for cardiovascular disease (CVD) 11, 12 including hypertension, obesity, diabetes and dyslipidemia 1, [13] [14] [15] . Several other traits and disorders have also been associated with blood pressure, including height 2, 3, 16 , osteoporosis 4, 17 , schizophrenia 5, 6, 18 , diabetes 7, 8, 19 , and autoimmune disorders 9, 20 . However, observational and clinical studies cannot fully elucidate the etiologic relationship between these phenotypes. Methods for assessing genetic pleiotropy offer great promise for delineating the basis of shared phenotypic correlations and for cost-effective identification of new loci 10, 21, 22 . This could be particularly meaningful for 'essential hypertension', where multiple pathogenic processes are likely involved 11, 12, 23 , and overlapping genetic associations with multiple phenotypes may be frequent. Here, we applied a recently developed genetic pleiotropy-informed analytical method for GWAS that captures more of the polygenic effects in complex disorders and traits (hereafter referred to as polygenic pleiotropy) 22 . We used this approach to leverage the power of multiple large independent GWAS for identifying SNPs exhibiting pleiotropy between SBP and 12 associated traits and disorders where recent GWAS results are available: bone mineral density (BMD) 24 , low density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL) cholesterol, triglycerides (TG) 25 , type 2 diabetes (T2D) 26 , body mass index (BMI) 27 , waist to hip ratio (WHR) 28 , height (HT) 29 , schizophrenia (SCZ) 30 , type 1 diabetes (T1D) 31 , Rheumatoid Arthritis (RA) 32 and Celiac Disease (CeD) 33, 34 . By combining data from these different GWAS, we hypothesized that the genetic pleiotropy-informed approach can improve discovery of SBP genes, and inform the etiologic relationship between blood pressure and epidemiologically related phenotypes.
METHODS

Participant Samples
We obtained complete GWAS results in the form of summary statistics p-values from public access websites or through collaboration with investigators (Table 1) . Details on the inclusion criteria and phenotype characteristics of the different GWAS are described in the original publications 4,25-28 . There was some overlap among several of the participants in the CVD risk factor GWAS and the SBP GWAS sample 4 . The relevant institutional review boards or ethics committees approved the research protocol of the individual GWAS and all participants gave written informed consent. All studies adhered to the principles of the Declaration of Helsinki.
Statistical Analyses
Genomic Control-We applied a control method using only intergenic SNPs to compute the inflation factor, λ GC and divided all test statistics by λ GC , as detailed in prior publications 21, 22 .
Conditional Quantile-Quantile (Q-Q) plots for pleiotropic enrichment-Enrichment of statistical association relative to that expected under the global null hypothesis can be visualized through Q-Q plots of nominal p-values obtained from GWAS summary statistics. Genetic enrichment results in a leftward shift in the Q-Q curve, corresponding to a larger fraction of SNPs with nominal −log 10 p-value greater than or equal to a given threshold. Conditional Q-Q plots are constructed by creating subsets of SNPs based on the significance of each SNP's association with a related phenotype, and computing Q-Q plots separately for each level of association (for further details, see references 21, 22) . We constructed conditional Q-Q plots of empirical quantiles of nominal -log 10 (p) values for SNP association with SBP for all SNPs, and for subsets of SNPs determined by the nominal p-values of their association with each of the 12 related phenotypes (-log 10 (p) ≥ 0, -log 10 (p) ≥ 1, -log 10 (p) ≥2, and -log 10 (p) ≥3 corresponding to p ≤ 1, p ≤ 0.1, p ≤ 0.01, and p ≤ 0.001, respectively). The nominal p-values (-log 10 (p)) are plotted on the y-axis, and the empirical quantiles (-log 10 (q), where q=1-cdf(p)) are plotted on the x-axis. To assess polygenic effects, we focused the conditional Q-Q plots on SNPs with nominal -log 10 (p) < 7.3 (corresponding to p > 5×10 −8 ).
Conditional False Discovery Rate (FDR)-Enrichment seen in the conditional Q-Q plots can be directly interpreted in terms of False Discovery Rate (FDR) 21, 22 (equivalent to 1 -True Discovery Rate (TDR) 35 ). We applied a conditional FDR method 22, 36, 37 , and constructed TDR plots, as described earlier 21, 22 , and detailed in Online Supplement (please see http://hyper.ahajournals.org).
Conditional statistics -test of association with Systolic Blood Pressure-To improve detection of SNPs associated with SBP, we conditioned SNPs based on p-values in the related phenotype 21, 22 . We then assigned a conditional FDR value (denoted as FDR SBP | related-phenotype ) for SBP to each SNP, for each related phenotype by interpolation, using a two-dimensional look-up table of conditional FDR values 21, 22 computed for each of the specific datasets used in the current study ( Figure S3 , please see http:// hyper.ahajournals.org). All SNPs with FDR SBP | related-phenotype < 0.01 (−log 10 (FDR SBP | related-phenotype ) > 2) in SBP given association with any of the 12 related phenotypes are listed in Table 1 after 'pruning' (i.e., removing all SNPs with r 2 > 0.2 based on 1000 Genomes Project linkage disequilibrium (LD) structure). A significance threshold of FDR < 0.01 corresponds to 1 false positive per 100 reported associations.
Conditional FDR Manhattan plots-To illustrate the localization of the genetic markers associated with SBP given the related phenotype effect, we used a 'Conditional FDR Manhattan plot', plotting all SNPs within an LD block in relation to their chromosomal locations. The strongest signal in each LD block was identified by ranking all SNPs in increasing order, based on the conditional FDR value for SBP, and then removing SNPs in LD r 2 > 0.2 with any higher ranked SNP. Thus, the selected locus was the most significantly associated with SBP in each LD block.
RESULTS
Pleiotropic enrichment -polygenic overlap
Conditional Q-Q plots for SBP conditioned on nominal p-values of association with LDL, BMI, BMD, T1D, SCZ, and CeD showed enrichment across different levels of significance ( Figure 1A -F). For LDL, the proportion of SNPs in the −log 10 (p LDL ) ≥ 3 category reaching a given significance level (e.g., −log 10 (p SBP ) > 6) was roughly 100 times greater than for −log 10 (p LDL ) ≥ 0 category (all SNPs), indicating a very high level of enrichment ( Figure  1A) . A similar level of enrichment was seen for BMI and SCZ ( Figure 1B ,C); CeD, T1D and BMD also showed a high level of enrichment ( Figure 1D -F). Weaker pleiotropic enrichment was seen for WHR ( Figure S1 , please see http://hyper.ahajournals.org), with little or no evidence for enrichment in RA, HDL, TG, T2D, HT ( Figure S1 , please see http:// hyper.ahajournals.org). We also illustrate the high level of polygenic pleiotropic enrichment in LDL, BMI, BMD, T1D, SCZ, and CeD using "Enrichment Plots" (Figure S2 , please see http://hyper.ahajournals.org).
Gene loci associated with SBP
The "conditional FDR" Manhattan plot in Figure 2 shows the 62 independent gene loci significantly associated with SBP based on conditional FDR < 0.01 obtained from associated phenotypes. The 30 complex loci and 32 single gene loci (after pruning) were located on 16 chromosomes (Table 2 ). Only 11 of these loci would have been discovered using standard statistical methods (Bonferroni correction; bold values in the "SBP p-value" column, Table 2 ). Using the FDR method, 25 loci were identified (bold values in the "SBP-FDR" column, Table 2 ). The remaining 37 loci would not have been identified in the current sample without using the pleiotropy-informed conditional FDR method. Of the 62 loci identified, 42 were novel; 20 were reported in the primary analysis of the current sample 4 .
Many of these new loci are located in regions with borderline significant association with SBP in previous studies 4 . Of interest, several loci had multiple pleiotropic SNPs from several associated phenotypes, indicating overlapping genetic factors among these phenotypes.
Follow-up Ingenuity Pathways Analysis (IPA) are presented in Table S3 and S4 (please see http://hyper.ahajournals.org) identifying the traits in the categories "Cardiovascular disease" or "Cardiovascular System Development and Function", respectively, that may be affected by the gene heterogeneities in the vicinity of the indicated SBP associated genes. Figure S4 , made by the network function in IPA, demonstrates that a large proportion of SBP associated genes are functionally related (please see http://hyper.ahajournals.org).
DISCUSSION
Our findings demonstrate polygenic pleiotropy between SBP and BMI, T1D, SCZ, CeD and BMD, with strongest pleiotropy between SBP and LDL. Combining GWAS data from multiple different phenotypes, we identify 62 SBP susceptibility loci, including 42 novel loci.
In the original SBP GWAS sample, 29 loci were identified 4 . By combining the original SBP sample with GWAS of epidemiologically related phenotypes, we found significant pleiotropic signals in 62 loci. Thus, even though the original SBP GWAS was quite large 4 , the increased power provided by additional GWAS of associated phenotypes together with the FDR method more than doubled gene discovery. These findings underline the costeffectiveness of the current statistical methods, and strongly suggest that SBP is a highly polygenic trait, in line with recent findings 38 .
Our findings also provide novel insights into the relationship between SBP and other major CVD risk factors, which frequently co-occur. The combination of dyslipidemia (primarily increased TG levels and decreased HDL levels), T2D, and high blood pressure forms the metabolic syndrome [12] [13] [14] [15] [16] . These results demonstrate an interesting genetic dissociation among cardiovascular risk factors. We found that LDL, a classic CVD risk factor, showed strongest pleiotropy with SBP while factors associated with the metabolic syndrome (TG, HDL, and T2D) showed little genetic pleiotropy with SBP. Further research is needed to determine whether there is strong genetic pleiotropy among the metabolic risk factors that would provide a genetic basis for the metabolic syndrome. The strong pleiotropy between LDL and SBP suggests that many genes related to lipid biology are pleiotropic with SBP and suggests common mechanisms related to atherosclerosis. This is further supported by the individual loci identified, of which the majority was based on conditional FDR with LDL, BMI or WHR. Several of the genes in LD with these new SBP-associated loci are involved in lipid metabolism and regulation. Lipid metabolism regulation may also underlie the observed pleiotropy between SBP and BMD, as suggested by gene expression in bone tissue 39 . However, age-related mechanisms may also underlie the overlap seen between SBP and BMD 40 .
Pleiotropy is defined as a single gene or variant being associated with more than one distinct phenotype 41 . Rather than representing genetic pleiotropy, it is also possible that some of the loci identified in the current study may underlie common aspects of the SBP and CVD phenotypes. Moreover, the shared genetic loci may also represent mediated pleiotropy. For example, for LDL and SBP the overlap may be due to the fact that lipid deposition leads to stiff arteries and thus higher blood pressure.
Another novel finding is the overlap between SBP and immune-related disorders, including CeD and T1D. Based on conditional analysis of these two phenotypes, 24 loci were identified. These phenotypes also showed strong polygenic pleiotropy, with clear enrichment in the Q-Q plots. While previous studies have suggested a link between T2D and SBP, the present study found an overlap between T1D, but not T2D, and SBP, suggesting immune-mediated rather than metabolic links between diabetes and SBP. The immunerelated mechanisms that are involved in SBP seem to be quite specific as we found little enrichment with RA, a prototypical auto-immune disorder. Moreover, while we found no or weak association with other inflammatory bowel disorders (data not shown), CeD a T-cell mediated disease 42 , showed much stronger enrichment. SCZ also showed strong enrichment with 12 independent SBP loci identified based on enrichment from the SCZ GWAS. In a previous study 21 we successfully used the polygenic pleiotropy approach to increase gene discovery in SCZ by enriching on CVD risk factors, identifying a shared genetic basis for the increased CVD mortality and higher incidence of hypertension in SCZ patients 18 . Our findings of several shared loci between SBP and SCZ point to common underlying mechanisms that warrant further experimental investigation.
Due to the overlap in some of the GWAS samples examined, we cannot exclude contribution from environmental or behavioral factors, or other non-genetic correlations. Still, our genetic pleiotropy results strongly imply the existence of shared pathophysiological processes across SBP and associated phenotypes because we controlled for pleiotropic inflation using genomic control correction of each primary single phenotype GWAS. Moreover, the overlapping loci are located on 16 chromosomes suggesting that the findings are not due to common genetic variation in potentially overlapping control groups. Further, the GWAS of blood lipids used the same sample to discover new genes for three different phenotypes 25 . Since we do not have access to additional samples or individual substudies, we cannot provide evidence of replication, which is a limitation of the current study. However, we have previously shown that the genetic findings obtained using the conditional FDR approach employed here replicate at the same or higher rate than findings obtained with traditional GWAS methods. Importantly, we have also demonstrated that these FDRbased methods increase sensitivity for a given specificity thus improving statistical power for SNP detection 22 . Due to the overlap in some of the GWAS samples examined, we cannot exclude contribution from environmental or behavioral factors, or other non-genetic correlations.
Another limitation of the current study is our inability to relate the genetic findings to clinical outcomes, such as stroke and congestive heart failure, as we do not have access to clinical outcome measures. However the current findings suggest that leveraging more powerful statistical techniques, building on Empirical Bayesian mixture models, may be a fruitful approach to better select plausible candidate SNPs for improved polygenic risk scores 43 that may lead to personalized medicine approaches and potentially individual prediction of disease risk. We are currently working towards developing prediction and stratification algorithms that incorporate multiple small effects to increase prediction and classification power.
In conclusion, we found substantial genetic overlap between SBP and several related conditions, including BMI, WHR, T1D, SCZ, CeD, BMD and in particular LDL. This suggests an etiological relationship between these phenotypes that could include lipid disturbances and certain immunological pathways.
PERSPECTIVES
The current results demonstrate the feasibility of using a genetic epidemiology framework that leverages overlap in genetic signal from independent GWAS of associated phenotypes, both for cost-effective gene discovery and for elucidating the shared genetic basis between related phenotypes. This approach identified 42 novel gene loci in SBP, arguing that GWAS have the potential to uncover more of the genetic basis of hypertension when new statistical methods are used. The observed polygenic overlap between SBP and several comorbid disorders indicates that the epidemiological associations are not mediated solely via lifestyle factors, but also reflect an etiological relation. Our findings also shed new light on the pathogenic mechanisms in SBP that warrants further investigation. The novel genetic loci identified here implicate genetic mechanisms related to lipid biology and the immune system in SBP. These findings may have implications for early diagnosis, prevention strategies and therapeutic regimens for hypertension.
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Novelty and Significance
What Is New?
-We used new statistical methods to improve gene discovery -We identified 42 novel gene loci associated with blood pressure -We demonstrated shared genes between blood pressure and several associated diseases/traits
What Is Relevant?
-The new gene loci may inform the underlying genetic mechanisms of hypertension -The genetic overlap with immune-mediated diseases and blood lipids suggests common mechanisms with hypertension -The findings may have implications for early diagnosis, prevention strategies and therapeutic regimens in hypertension
Summary
We identified 42 new gene loci for blood pressure, and found genetic overlap between blood pressure and several associated diseases and traits, particularly immune-mediated diseases and blood lipids. This suggests an etiological relationship between hypertension and lipid disturbances and immunological abnormalities. 'Conditional FDR Manhattan plot' of conditional -log 10 (FDR) values for Systolic Blood Pressure (SBP) alone (black) and SBP given the associated phenotypes low density lipoprotein cholesterol (LDL; SBP|LDL, red), body mass index (BMI; SBP|BMI, orange), bone mineral density (BMD; SBP|BMD, green), type 1 diabetes (T1D; SBP|T1D, purple), schizophrenia (SCZ; SBP|SCZ; turquois) and celiac disease (CeD; SBP|CeD, blue). SNPs with conditional -log 10 FDR > 2 (i.e. FDR < 0.01) are shown with large points. A black circle around the large points indicates the most significant SNP in each LD block and this SNP was annotated with the closest gene which is listed above the symbols in each locus, except for the HLA region on chromosome 6, and in Table S2 (please see http:// hyper.ahajournals.org). The figure shows the localization of 62 loci on 16 chromosomes (1-12, 15-17 and 20) . Details for the loci with -log 10 FDR > 2 (i.e. FDR < 0.01) are shown in Table 1 . Table 1 The GWAS data used in the current study Disease/Trait N # SNPs Table 2 Independent loci associated with SBP through Conditional FDR (<0.01) with associated phenotypes. 
Locus SNP Pos Gene chr SBP p-value SBP FDR Min cond FDR Associated Phenotype
